You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,241,662


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,241,662
Title:Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
Abstract: The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma concentration of oxybutynin metabolites, such as N-desethyloxybutynin, which is presumed to be contributing at least in part to some of the adverse drug experiences, while maintaining sufficient oxybutynin plasma concentration to benefit a subject with oxybutynin therapy. The invention also provides isomers of oxybutynin and its metabolites that meet these characteristics of minimized incidence and/or severity of adverse drug experiences, and maintenance of beneficial and effective therapy for overactive bladder. In some aspects, the composition may be presented in the form of an unoccluded or free form topically administered gel.
Inventor(s): Ebert; Charles D. (Salt Lake City, UT), Sanders; Steven W. (Salt Lake City, UT)
Assignee: Watson Laboratories, Inc. (Salt Lake City, UT)
Application Number:11/645,076
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,241,662: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,241,662, providing a detailed analysis of its scope, claims, and the broader patent landscape.

Understanding Patent Scope and Claims

Before diving into the specifics of US Patent 8,241,662, it is essential to understand what patent scope and claims entail.

Patent Scope

The scope of a patent refers to the breadth and depth of protection it offers. It is often measured using metrics such as independent claim length and independent claim count, as discussed in research on patent scope[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of the protection granted by the patent. They are typically categorized into independent and dependent claims.

Identifying the Patent

To analyze US Patent 8,241,662, we first need to identify the patent and its key components.

Patent Details

  • Patent Number: 8,241,662
  • Title: (This would typically be found in the patent document itself or through a patent search database)
  • Inventors: (Similarly, this information is available in the patent document)
  • Assignee: (The entity to which the patent is assigned)
  • Filing Date: (The date when the patent application was filed)
  • Grant Date: (The date when the patent was granted)

Conducting a Preliminary Patent Search

To gather detailed information about the patent, one would use resources such as the USPTO's Patent Public Search tool or other international patent databases.

Using USPTO Resources

The USPTO provides several tools for searching patents, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool offers enhanced access to prior art and modern interfaces for searching patents[1].

Analyzing the Claims of US Patent 8,241,662

Independent Claims

Independent claims define the invention in its broadest terms and are not dependent on other claims. These claims are critical in determining the scope of the patent.

Dependent Claims

Dependent claims narrow down the invention further and are dependent on one or more independent claims. They often add specific details or limitations to the independent claims.

Evaluating Patent Scope Metrics

Research suggests that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Claim Length and Count

  • Independent Claim Length: Longer independent claims may indicate a more complex invention but could also suggest broader scope.
  • Independent Claim Count: A higher number of independent claims might indicate a broader scope but could also complicate the examination process.

Examining the Patent Family

Understanding the patent family is crucial for assessing the overall protection and potential for future patents.

Continuations and Continuations-in-Part

If the patent is part of a family, it may include continuations or continuations-in-part, which can extend the scope of protection or introduce new claims[4].

International Patent Landscape

To fully understand the patent's scope, it is essential to look at the international landscape.

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping to identify the patent family and related applications globally[1].

Search International Patent Offices

Searching databases from other international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal if similar patents exist abroad[1].

Legal and Practical Considerations

Obviousness-Type Double Patenting (ODP)

Ensuring that the patent does not fall under obviousness-type double patenting is crucial. This involves checking if the claims are substantially the same as those in another patent by the same inventor[4].

Patent Term Adjustment (PTA)

Understanding any Patent Term Adjustments (PTA) granted due to USPTO delays can impact the patent's expiration date and its overall scope[4].

Case Law and Precedents

Reviewing relevant case law, such as decisions from the United States Court of Appeals for the Federal Circuit, can provide insights into how similar patents have been treated in the past.

Example: In re Cellect

The case of In re Cellect highlights the importance of ODP and PTA in determining the validity and scope of patent claims. The court's decision on whether an ODP analysis should consider PTA can be instructive for similar cases[4].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are crucial metrics for evaluating patent scope.
  • International Search: Searching international patent databases is essential for understanding the global patent landscape.
  • Legal Considerations: Ensuring compliance with ODP and understanding PTA are vital for maintaining the validity of patent claims.
  • Case Law: Reviewing relevant case law can provide valuable insights into the treatment of similar patents.

FAQs

What is the importance of independent claims in a patent?

Independent claims define the invention in its broadest terms and are critical in determining the scope of the patent.

How can I search for international patents related to my invention?

You can use databases such as the EPO's esp@cenet, JPO's patent database, and WIPO's PATENTSCOPE to search for international patents.

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA.

How does Patent Term Adjustment (PTA) affect the scope of a patent?

PTA can extend the term of a patent due to USPTO delays during prosecution, but it does not extend the term past the date of a terminal disclaimer.

Where can I find detailed information about a specific US patent?

You can use the USPTO's Patent Public Search tool or visit the USPTO Public Search Facility to find detailed information about a specific US patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. United States Court of Appeals for the Federal Circuit - In re Cellect: https://cafc.uscourts.gov/opinions-orders/22-1293.OPINION.8-28-2023_2181381.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,241,662

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,241,662

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 488233 ⤷  Subscribe
Australia 2001253782 ⤷  Subscribe
Australia 2003287377 ⤷  Subscribe
Australia 2003294239 ⤷  Subscribe
Australia 2010200418 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.